{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:34:21Z","timestamp":1778664861747,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.cbpa.2009.05.007","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T05:37:04Z","timestamp":1245649024000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Creating zinc monkey wrenches in the treatment of epigenetic disorders"],"prefix":"10.1016","volume":"13","author":[{"given":"Jay Hans","family":"Kalin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle Vincent","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan Paul","family":"Kozikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2009.05.007_bib1","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.93.12.5705","article-title":"Second generation hybrid polar compounds are potent inducers of transformed cell differentiation","volume":"93","author":"Richon","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2009.05.007_bib2","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1073\/pnas.95.6.3003","article-title":"A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases","volume":"95","author":"Richon","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2009.05.007_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib4","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cbpa.2009.05.007_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0707166","article-title":"HDAC inhibitors as anti-inflammatory agents","volume":"150","author":"Adcock","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: What are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib8","doi-asserted-by":"crossref","first-page":"e2445","DOI":"10.1371\/journal.pone.0002445","article-title":"HDAC inhibitors act with 5-aza-2\u2032-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells","volume":"3","author":"Chai","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cbpa.2009.05.007_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00277-008-0477-9","article-title":"Current status of epigenetic treatment in myelodysplastic syndromes","volume":"87","author":"Kuendgen","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ijc.23994","article-title":"Epigenetic regulation and molecular characterization of C\/EBPalpha in pancreatic cancer cells","volume":"124","author":"Kumagai","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cbpa.2009.05.007_bib11","first-page":"767","article-title":"Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells","volume":"33","author":"Lee","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11060-008-9732-0","article-title":"Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2\u2032-deoxycytidine in glioma cells","volume":"92","author":"Oi","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1158\/1535-7163.MCT-07-0526","article-title":"Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor","volume":"7","author":"Beltran","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cbpa.2009.05.007_bib14","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.1073\/pnas.0801868105","article-title":"Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist","volume":"105","author":"Frew","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2009.05.007_bib15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/sj.leu.2405079","article-title":"Inhibition of MEK\/ERK signaling synergistically potentiates histone deacetylase inhibitor-induced growth arrest, apoptosis and acetylation of histone H3 on p21waf1 promoter in acute myelogenous leukemia cell","volume":"22","author":"Nishioka","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cbpa.2009.05.007_bib16","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/ijc.23885","article-title":"Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer","volume":"123","author":"Bjorkman","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cbpa.2009.05.007_bib17","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.bjc.6604295","article-title":"MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN\/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours","volume":"98","author":"Khandelwal","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cbpa.2009.05.007_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-007-9505-1","article-title":"Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA)","volume":"87","author":"Spiller","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib19","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","article-title":"Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition","volume":"28","author":"Leng","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.cbpa.2009.05.007_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2008.08.039","article-title":"Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors","volume":"196","author":"Zhu","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.cbpa.2009.05.007_bib21","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease","volume":"17","author":"Pallos","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cbpa.2009.05.007_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cmdc.200700314","article-title":"Chemistry, biology, and QSAR studies of substituted biaryl hydroxamates and mercaptoacetamides as HDAC inhibitors-nanomolar-potency inhibitors of pancreatic cancer cell growth","volume":"3","author":"Kozikowski","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib23","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1021\/jm701606b","article-title":"A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum","volume":"51","author":"Chen","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib24","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1021\/jm800251w","article-title":"Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor","volume":"51","author":"Zhou","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/1535-7163.MCT-07-2026","article-title":"MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo","volume":"7","author":"Fournel","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cbpa.2009.05.007_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/187152007781668698","article-title":"Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective","volume":"7","author":"Balakin","year":"2007","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib27","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.2174\/138161207781663064","article-title":"The pharmaceutical potential of histone deacetylase inhibitors","volume":"13","author":"Elaut","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cbpa.2009.05.007_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.biocel.2008.08.020","article-title":"Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead","volume":"41","author":"Mai","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib29","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.yexcr.2008.01.010","article-title":"HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity","volume":"314","author":"Kaler","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cbpa.2009.05.007_bib30","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/sj.jid.5701216","article-title":"Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma","volume":"128","author":"Murakami","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2008.9","article-title":"A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas","volume":"22","author":"Balasubramanian","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cbpa.2009.05.007_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12185-008-0226-9","article-title":"Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma","volume":"89","author":"Kitazoe","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cbpa.2009.05.007_bib33","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/1078-0432.CCR-08-1918","article-title":"Dual degradation of aurora A and B kinases by the histone deacetylase inhibitor LBH589 induces G2-M arrest and apoptosis of renal cancer cells","volume":"15","author":"Cha","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cbpa.2009.05.007_bib34","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/jm070178x","article-title":"Functional differences in epigenetic modulators-superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies","volume":"50","author":"Kozikowski","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1523\/JNEUROSCI.3200-07.2008","article-title":"Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1\/cip1) in cell cycle-independent neuroprotection","volume":"28","author":"Langley","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.cbpa.2009.05.007_bib36","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.bmcl.2005.01.006","article-title":"Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors","volume":"15","author":"Chen","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","article-title":"Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling","volume":"30","author":"Guidotti","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cbpa.2009.05.007_bib38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cbpa.2009.05.007_bib39","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1523\/JNEUROSCI.0296-07.2007","article-title":"Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation","volume":"27","author":"Vecsey","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.cbpa.2009.05.007_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mcn.2008.06.009","article-title":"Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice","volume":"39","author":"Fontan-Lozano","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.cbpa.2009.05.007_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nature05772","article-title":"Recovery of learning and memory is associated with chromatin remodelling","volume":"447","author":"Fischer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2009.05.007_bib42","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","article-title":"Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation","volume":"27","author":"Dompierre","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.cbpa.2009.05.007_bib43","doi-asserted-by":"crossref","first-page":"e1958","DOI":"10.1371\/journal.pone.0001958","article-title":"HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model","volume":"3","author":"Rai","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cbpa.2009.05.007_bib44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/cmdc.200800461","article-title":"Studies of benzamide- and thiol-based histone deacetylase inhibitors in models of oxidative-stress-induced neuronal death: identification of some HDAC3-selective inhibitors","volume":"4","author":"Chen","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2007.06.116","article-title":"Defective cholesterol traffic and neuronal differentiation in neural stem cells of Niemann\u2013Pick type C disease improved by valproic acid, a histone deacetylase inhibitor","volume":"360","author":"Kim","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cbpa.2009.05.007_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cbpa.2009.05.007_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2008.11.009","article-title":"Suppression of caspase-11 expression by histone deacetylase inhibitors","volume":"378","author":"Heo","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cbpa.2009.05.007_bib48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3858\/emm.2008.40.5.574","article-title":"Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model","volume":"40","author":"Choi","year":"2008","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cbpa.2009.05.007_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brainres.2008.05.085","article-title":"HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats","volume":"1226","author":"Zhang","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.cbpa.2009.05.007_bib50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.joca.2007.10.014","article-title":"Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model","volume":"16","author":"Nasu","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.cbpa.2009.05.007_bib51","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/b703830p","article-title":"Isoform-selective histone deacetylase inhibitors","volume":"37","author":"Bieliauskas","year":"2008","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.cbpa.2009.05.007_bib52","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1021\/jm7015254","article-title":"Structural origin of selectivity in class II-selective histone deacetylase inhibitors","volume":"51","author":"Estiu","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib53","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1021\/jm800081j","article-title":"Residues in the 11 A channel of histone deacetylase 1 promote catalytic activity: implications for designing isoform-selective histone deacetylase inhibitors","volume":"51","author":"Weerasinghe","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib54","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/jm800079s","article-title":"A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo","volume":"51","author":"Jones","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib55","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/jm801128g","article-title":"Non-peptide macrocyclic histone deacetylase inhibitors","volume":"52","author":"Oyelere","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib56","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1016\/j.bmcl.2008.10.052","article-title":"SAR profiles of spirocyclic nicotinamide derived selective HDAC1\/HDAC2 inhibitors (SHI-1:2)","volume":"18","author":"Methot","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib57","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bmcl.2007.11.047","article-title":"Optimization of biaryl selective HDAC1&2 inhibitors (SHI-1:2)","volume":"18","author":"Witter","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib58","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.bmcl.2008.12.083","article-title":"Parallel medicinal chemistry approaches to selective HDAC1\/HDAC2 inhibitor (SHI-1:2) optimization","volume":"19","author":"Kattar","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib59","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.bmcl.2008.02.026","article-title":"2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors","volume":"18","author":"Jones","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib60","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1016\/j.bmcl.2008.09.076","article-title":"2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors","volume":"18","author":"Muraglia","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib61","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bmcl.2007.12.031","article-title":"Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1\/HDAC2 inhibitors (SHI-1:2)","volume":"18","author":"Methot","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib62","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bmcl.2008.12.045","article-title":"Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors","volume":"19","author":"Smil","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.cbpa.2009.05.007_bib63","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jm8002894","article-title":"Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6","volume":"51","author":"Kozikowski","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.cbpa.2009.05.007_bib64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/138161208783885353","article-title":"Chemical origins of isoform selectivity in histone deacetylase inhibitors","volume":"14","author":"Butler","year":"2008","journal-title":"Curr Pharm Des"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593109000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593109000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:23:41Z","timestamp":1761272621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593109000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1367593109000702"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2009.05.007","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Creating zinc monkey wrenches in the treatment of epigenetic disorders","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2009.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}